AstraZeneca makes appointment in Russia
This article was originally published in Scrip
AstraZeneca has appointed Nenad Pavletic general manager of its Russian division. He succeeds Frederic Gerard. Mr Pavletic's most recent job was AstraZeneca's general manager in ex-Soviet republics, including the Baltic states, and Balkan countries; before that he led the company's divisions in Slovenia and Romania.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.